Specialty pharmaceuticals company, Impax Laboratories Inc. (NASDAQ:IPXL)  released on Wednesday that it aims to offer $500M aggregate principal amount of convertible senior notes owing 2022 in a private offering to qualified institutional buyers. In connection by means of the offering, the firm anticipates to grant the initial purchasers an option […]